Sleep changes more than how alert we feel the next morning. Researchers are investigating how it also changes the movement of fluid through the brain, helping explain a biological process often described as waste clearance. Studies in people are bringing this question closer to direct measurement, while leaving important questions about long-term health unanswered. The developing science centres on the glymphatic system: pathways associated with blood vessels through which cerebrospinal fluid exchanges with fluid surrounding brain cells. This exchange can help transport dissolved substances. Understanding it requires separating three questions: where fluid travels, what drives its movement, and whether changing that movement improves health. Following fluid through the human brain A 2024 proof-of-principle study in PNAS investigated the first question in five people undergoing neurosurgical care. Researchers used contrast-enhanced MRI to follow cerebrospinal fluid. They observed contrast moving along spaces around blood vessels and into surrounding brain tissue, supporting the existence of a glymphatic pathway in humans. The study was small and involved patients already receiving specialised care. Its value lies in demonstrating a route that researchers had previously characterised largely in animals. It did not establish how efficiently the pathway works in everyone, identify an ideal sleep routine, or show that enhancing it prevents neurological disease. Sleep may help drive the process To explore what moves the fluid, a 2025 study in Cell examined naturally sleeping mice. The investigators linked slow fluctuations in norepinephrine, a chemical messenger, with changes in blood-vessel volume and cerebrospinal fluid. Their experiments supported the idea that rhythmic vessel movement helps pump fluid through the brain during non-rapid-eye-movement sleep. This suggests that the organisation of sleep matters alongside the simple distinction between being asleep and awake. However, observations in mice cannot establish the size of the effect in humans. The same study also examined a sleep medicine, but its animal findings should not be treated as instructions to start, stop or change a prescribed treatment. Measuring a hidden process without invasive sampling A separate challenge is developing practical ways to track fluid exchange. A 2025 Nature Biomedical Engineering study described an investigational wearable device using electrical impedance measurements to estimate changes in brain tissue resistance. The measurements tracked sleep-associated changes relevant to fluid movement and predicted exchange assessed using contrast-enhanced MRI. This approach could make repeated measurements more feasible than techniques requiring specialised imaging. It remains a research method, however. A measurement related to fluid transport is not equivalent to directly collecting every substance leaving the brain. Validation across different populations and conditions will be essential before such signals can support routine clinical decisions. A human study connects sleep with protein transport In Nature Communications in January 2026, researchers reported a randomized crossover trial involving 39 participants. They compared normal sleep with sleep deprivation, combining overnight physiological monitoring, blood biomarkers and a model of how substances move between brain tissue, cerebrospinal fluid and blood. The findings supported greater overnight transport of amyloid beta and tau into blood during normal sleep. These proteins are relevant to Alzheimer's disease research. Importantly, a higher morning blood concentration in this experimental setting could reflect increased clearance from the brain; it should not automatically be interpreted as greater disease burden. This was a study of short-term physiology, not a trial showing that a sleep intervention prevents dementia. Its interpretation depends partly on modelling and investigational measurements. Larger studies, independent replication and longer follow-up are needed to connect these findings with meaningful changes in memory or disease progression. Study design also matters when interpreting headlines. Comparing sleep and wakefulness within the same participants helps reduce differences between individuals, but a controlled laboratory night still captures only a narrow slice of everyday life. Research must account for that gap before findings become personalised advice. What the evidence means now Together, these studies make brain fluid transport a more measurable scientific question. They also show why the popular phrase “brain detox” can be misleading: an intricate biological process is not a consumer treatment, and a promising mechanism does not establish a cure. The next step is to test whether interventions can reliably change clearance in people and whether those changes improve outcomes. For readers, the useful distinction is between evidence that sleep affects brain physiology and evidence that a specific product or treatment prevents disease. The former is growing; the latter requires its own rigorous clinical testing. Image: KATRIN BOLOVTSOVA / Pexels. Illustrative photograph; the person pictured is not a study participant.